600867 通化东宝
已收盘 12-19 15:00:00
资讯
新帖
简况
通化东宝:并未出现公司控股股东出借股份的情况
证券之星 · 12-13
通化东宝:并未出现公司控股股东出借股份的情况
通化东宝12月12日主力资金流出261万元 连续3日减仓
市场透视 · 12-12
通化东宝12月12日主力资金流出261万元 连续3日减仓
通化东宝最新公告:GLP-1/GIP双靶点受体激动剂注射用THDBH120获得Ia期临床试验总结报告
证券之星 · 12-06
通化东宝最新公告:GLP-1/GIP双靶点受体激动剂注射用THDBH120获得Ia期临床试验总结报告
通化东宝(600867.SH):THDBH120获Ia期临床试验总结报告 研究结果达到主要终点目标
智通财经网 · 12-06
通化东宝(600867.SH):THDBH120获Ia期临床试验总结报告 研究结果达到主要终点目标
通化东宝12月03日遭主力抛售751万元 环比增加103.52%
市场透视 · 12-03
通化东宝12月03日遭主力抛售751万元 环比增加103.52%
概念掘金 | 医药巨头在华新建胰岛素生产基地,这些公司或成为“赢家”
格隆汇 · 12-03
概念掘金 | 医药巨头在华新建胰岛素生产基地,这些公司或成为“赢家”
通化东宝回购进展:已回购1933万股,金额达1.49亿元
财中社 · 12-02
通化东宝回购进展:已回购1933万股,金额达1.49亿元
通化东宝(600867.SH)累计回购0.98%股份 耗资1.49亿元
智通财经 · 12-02
通化东宝(600867.SH)累计回购0.98%股份 耗资1.49亿元
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
通化东宝:公司在研新一代胰岛素超速效赖脯胰岛素,目前处于临床III期阶段
证券之星 · 11-27
通化东宝:公司在研新一代胰岛素超速效赖脯胰岛素,目前处于临床III期阶段
通化东宝11月19日收涨0.12% 主力资金逆市抛售
市场透视 · 11-19
通化东宝11月19日收涨0.12% 主力资金逆市抛售
总规模突破160亿 沪市70余家公司获回购增持再贷款支持
美港电讯 · 11-17
总规模突破160亿 沪市70余家公司获回购增持再贷款支持
通化东宝:11月13日高管王君业增持股份合计5万股
证券之星 · 11-15
通化东宝:11月13日高管王君业增持股份合计5万股
通化东宝控股股东权益变动达1% 增持股份超205万股
财中社 · 11-15
通化东宝控股股东权益变动达1% 增持股份超205万股
通化东宝:公司胰岛素新的中标价格从各地执行时间要求时间点开始执行
证券之星 · 11-15
通化东宝:公司胰岛素新的中标价格从各地执行时间要求时间点开始执行
11月15日通化东宝发布公告,其股东增持205.01万股
证券之星 · 11-15
11月15日通化东宝发布公告,其股东增持205.01万股
通化东宝:11月8日高管王君业增持股份合计14.82万股
证券之星 · 11-11
通化东宝:11月8日高管王君业增持股份合计14.82万股
通化东宝11月11日遭主力抛售2712万元 环比增加102.84%
市场透视 · 11-11
通化东宝11月11日遭主力抛售2712万元 环比增加102.84%
通化东宝:11月7日高管王君业增持股份合计5万股
证券之星 · 11-08
通化东宝:11月7日高管王君业增持股份合计5万股
回购增持再贷款持续发力,超200亿元额度已“花落”74家上市公司
银柿财经 · 11-08
回购增持再贷款持续发力,超200亿元额度已“花落”74家上市公司
暂无数据
公司概况
公司名称:
通化东宝药业股份有限公司
所属行业:
医药制造业
上市日期:
1994-08-24
主营业务:
通化东宝药业股份有限公司主要从事糖尿病及内分泌治疗领域生物制品、中成药、化学药等药品的研发、生产和销售。主要产品包括精蛋白人胰岛素混合注射液(30R)、精蛋白重组人胰岛素混合注射液(40/60)、精蛋白人胰岛素混合注射液(50R)、人胰岛素注射液、精蛋白人胰岛素注射液、甘精胰岛素注射液、门冬胰岛素注射液、门冬胰岛素30注射液、门冬胰岛素50注射液、利拉鲁肽注射液、瑞格列奈片、恩格列净片、镇脑宁胶囊。公司拥有国家级企业技术中心、国家GMP和欧盟GMP认证的生产车间。被国家认定为高新技术企业、国家技术创新示范企业、ISO14001环境体系认证企业。
发行价格:
6.50
{"stockData":{"symbol":"600867","market":"SH","secType":"STK","nameCN":"通化东宝","latestPrice":8.26,"timestamp":1734591600000,"preClose":8.29,"halted":0,"volume":12224402,"delay":0,"floatShares":1982000000,"shares":1982000000,"eps":0.1723,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.03,"latestTime":"12-19 15:00:00","open":8.23,"high":8.28,"low":8.13,"amount":100000000,"amplitude":0.0181,"askPrice":8.26,"askSize":138,"bidPrice":8.25,"bidSize":324,"shortable":0,"etf":0,"ttmEps":0.1723,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"adjPreClose":8.29,"symbolType":"stock","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":9.12,"lowLimit":7.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1981734074,"pbRate":2.55,"roa":"--","roe":"--","epsLYR":0.59,"committee":0.176938,"marketValue":16369000000,"floatMarketCap":16369000000,"peRate":47.939641,"changeRate":-0.0036,"turnoverRate":0.0062,"status":1},"requestUrl":"/m/hq/s/600867/tweets","defaultTab":"tweets","newsList":[{"id":"2491682323","title":"通化东宝:并未出现公司控股股东出借股份的情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2491682323","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491682323?lang=zh_cn&edition=full","pubTime":"2024-12-13 19:00","pubTimestamp":1734087636,"startTime":"0","endTime":"0","summary":"证券之星消息,通化东宝12月13日在投资者关系平台上答复投资者关心的问题。公司四季度全面恢复正常发货,目前渠道中库存处于较低水平。还是需要拿出更有效的措施才行,不指望跑赢股指,至少同步吧通化东宝董秘:感谢您对公司的关注。并未出现公司控股股东出借股份的情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300037711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600867","BK0239","BK0196"],"gpt_icon":0},{"id":"2491339724","title":"通化东宝12月12日主力资金流出261万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491339724","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491339724?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:21","pubTimestamp":1733988060,"startTime":"0","endTime":"0","summary":"12月12日, 通化东宝股价涨0.94%,报收8.60元,成交金额1.42亿元,换手率0.84%,振幅1.88%,量比1.10。通化东宝今日主力资金净流出261万元,连续3日净流出,上一交易日主力净流出219万元,今日环比增加19.18%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为60.00%,平均跌幅为1.77%。该股近5个交易日上涨2.99%,主力资金累计净流出709万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出1.94亿元,其中净流出天数为17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212154307ab71c95e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212154307ab71c95e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0239","600867","BK0188"],"gpt_icon":0},{"id":"2489940890","title":"通化东宝最新公告:GLP-1/GIP双靶点受体激动剂注射用THDBH120获得Ia期临床试验总结报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2489940890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489940890?lang=zh_cn&edition=full","pubTime":"2024-12-06 16:10","pubTimestamp":1733472628,"startTime":"0","endTime":"0","summary":"通化东宝公告,全资子公司东宝紫星(杭州)生物医药有限公司完成了一项关键Ia期临床试验并获得临床试验总结报告,研究结果显示达到主要终点目标。公司已同步开展在2型糖尿病患者中及在肥胖受试者中评价注射用THDBH120多次给药的安全性、耐受性、药代动力学和药效动力学的随机、双盲、安慰剂对照的两项Ib期临床试验,目前试验进展顺利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600026075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK1576","BK0188","BK0196","BK1583","BK0239","BK1141","03347"],"gpt_icon":0},{"id":"2489472794","title":"通化东宝(600867.SH):THDBH120获Ia期临床试验总结报告 研究结果达到主要终点目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2489472794","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489472794?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:35","pubTimestamp":1733470535,"startTime":"0","endTime":"0","summary":"智通财经APP讯,通化东宝 发布公告,公司全资子公司东宝紫星(杭州)生物医药有限公司完成了一项关键Ia期临床试验并获得临床试验总结报告,研究结果显示达到主要终点目标。在开展上述I期研究同时,公司同步开展了在2型糖尿病患者中及在肥胖受试者中评价注射用THDBH120多次给药的安全性、耐受性、药代动力学和药效动力学的随机、双盲、安慰剂对照的两项Ib期临床试验,目前试验进展顺利。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1576","BK1583","BK0188","600867","BK1141","BK0239","03347","BK0196"],"gpt_icon":0},{"id":"2488613949","title":"通化东宝12月03日遭主力抛售751万元 环比增加103.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488613949","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488613949?lang=zh_cn&edition=full","pubTime":"2024-12-03 15:19","pubTimestamp":1733210385,"startTime":"0","endTime":"0","summary":"12月03日, 通化东宝股价跌0.47%,报收8.48元,成交金额1.11亿元,换手率0.67%,振幅1.29%,量比0.94。通化东宝今日主力资金净流出751万元,连续5日净流出,上一交易日主力净流出369万元,今日环比增加103.52%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为66.67%,平均跌幅为1.10%。该股近5个交易日上涨0.83%,主力资金累计净流出4658万元;近20日主力资金累计净流出2.27亿元,其中净流出天数为17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203153120a268a3ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203153120a268a3ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600867","BK0196","BK0239","BK0188"],"gpt_icon":0},{"id":"2488951803","title":"概念掘金 | 医药巨头在华新建胰岛素生产基地,这些公司或成为“赢家”","url":"https://stock-news.laohu8.com/highlight/detail?id=2488951803","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488951803?lang=zh_cn&edition=full","pubTime":"2024-12-03 10:11","pubTimestamp":1733191895,"startTime":"0","endTime":"0","summary":"创造了公司在华最大单笔投资记录","market":"hk","thumbnail":"https://img3.gelonghui.com/02fa1-16106239-1718-4fab-8750-6efec1b6d747.jpg?guru_height=3672&guru_width=5184","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/02fa1-16106239-1718-4fab-8750-6efec1b6d747.jpg?guru_height=3672&guru_width=5184"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1419204","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0175","BK0209","BK1574","BK0028","BK0132","BK0239","LU1064131003.USD","LU1969619763.USD","603087","600276","BK0012","BK1515","BK0188","09939","LU2328871848.SGD","LU1064130708.USD","BK1161","BK0187","LU2488822045.USD","LU1328615791.USD","600867","BK0060","BK0196","LU2148510915.USD","000963","601089","BK0183","LU0405327148.USD","LU0405327494.USD"],"gpt_icon":0},{"id":"2488237576","title":"通化东宝回购进展:已回购1933万股,金额达1.49亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488237576","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488237576?lang=zh_cn&edition=full","pubTime":"2024-12-02 16:12","pubTimestamp":1733127146,"startTime":"0","endTime":"0","summary":"财中社12月2日电通化东宝 发布关于2024年第二期以集中竞价交易方式回购公司股份进展情况的公告。公告指出,公司于2024年7月11日首次披露回购方案,预计回购金额在1.8亿元至2亿元之间,回购用途为减少注册资本。截至2024年11月,公司已累计回购1933万股,占总股本的0.98%。2024年前三季度,通化东宝实现收入14.48亿元,归母净利润-6637万元。文章来源:财中社通化东宝回购进展:已回购1933万股,金额达1.49亿元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161920a265bd10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161920a265bd10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600867","BK0196","BK0239"],"gpt_icon":0},{"id":"2488628357","title":"通化东宝(600867.SH)累计回购0.98%股份 耗资1.49亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488628357","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488628357?lang=zh_cn&edition=full","pubTime":"2024-12-02 16:09","pubTimestamp":1733126964,"startTime":"0","endTime":"0","summary":"智通财经APP讯,通化东宝(600867.SH)发布公告,截至2024年11月末,公司通过集中竞价交易方式已累计回购股份数量为1932.91万股,占公司目前总股本的比例为0.98%,成交的最高价为8.45元/股,成交的最低价为7.32元/股,累计成交的总金额为1.49亿元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1218908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600867","BK0196","BK0239","BK0188"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上,据医保局日前披露,2024年1-10月医保统筹基金收入23065.07亿元,同比增长8.9%;2024年1-10月统筹支出19165.88亿元,同比增长8.9%。对此,国泰君安表示,1-10月医保统筹基金运行平稳,收入稳健增长,支出增速逐月收窄。国金证券表示,由于多方面因素,医药板块景气度在2021年后经历了长时间的下行。2024年11月7日,国家医保局召开了座谈会,强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721","603108","BK0185","688163","603087","600976","600351","603858","600436","603939","688575","600380","600998","688331","603309","688266","600200","688278","600055","605199","603392","600161","600521","BK0070","600572","688192","688276","603439","600771","688506","688315","603567","600511","BK0096","688298","688356","600329","688193","600332","688581","688180","688336","600851","688076","688139","688198","600196","603127","600085","600129","688656","600080","603301","603658","600566","688373","688189","688067","605177","BK0012","600867","688221","688050","688488","688578","688687","688212","688105","688301","688670","600056","688046","688382","688091","688389","603456","688062","688085","603707","688566","600739","688235","688247","688428","600079","600062","688520","600763","603882","BK0239","688177","159938","603259","600252","603538","603896","688029","600420","688117","688658","688073","688351","BK0188","688222","688137","601607","688202","603590","600422","600535","688626","BK0028","688114","688176","600529","688690","600276","688443","600211","600285","688617","688767","688271","688321","688166","603367","603233","688161","600488"],"gpt_icon":0},{"id":"2486686842","title":"通化东宝:公司在研新一代胰岛素超速效赖脯胰岛素,目前处于临床III期阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2486686842","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486686842?lang=zh_cn&edition=full","pubTime":"2024-11-27 19:00","pubTimestamp":1732705247,"startTime":"0","endTime":"0","summary":"公司在研新一代胰岛素超速效赖脯胰岛素,目前处于临床III期阶段。此外,公司正在开展胰岛素周制剂的临床前研究工作。应收账款周转率下降主要系今年上半年受集采续约产生的发货与差价一次性冲销或返还的短期影响,营业收入下滑导致。公司今年单三季度营收已迅速恢复,对应的单季度应收账款周转率较去年单三季度已实现提升。预计未来随着营收的进一步恢复,应收账款周转率将逐步改善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700031852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","BK0188","600867"],"gpt_icon":0},{"id":"2484299326","title":"通化东宝11月19日收涨0.12% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2484299326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484299326?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:20","pubTimestamp":1732000825,"startTime":"0","endTime":"0","summary":"11月19日, 通化东宝股价涨0.12%,报收8.55元,成交金额1.70亿元,换手率1.01%,振幅1.99%,量比0.62。通化东宝今日主力资金净流出3354万元,上一交易日主力净流入22万元。该股近5个交易日下跌4.68%,主力资金累计净流出7715万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1.80亿元,其中净流出天数为13日。该股主力净额占比0.20%,A股市场排名4757/5000,低于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119153325abce8778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119153325abce8778&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600867","BK0196","BK0239","BK0188"],"gpt_icon":0},{"id":"2484943681","title":"总规模突破160亿 沪市70余家公司获回购增持再贷款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2484943681","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484943681?lang=zh_cn&edition=full","pubTime":"2024-11-17 19:09","pubTimestamp":1731841785,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0006","BK1505","BK0253","BK0095","603986","BK0013","BK0214","BK0239","BK0132","BK0188","SG9999001440.SGD","LU1969619763.USD","BK0196","BK0231","601919","BK0089","600699","BK0183","BK0224","600570","BK0028","LU1655091616.SGD","LU2328871848.SGD","BK1535","SGXZ81163826.USD","BK0130","BK0102","BK0070","BK0142","BK1103","600867","BK0054","BK0220","BK0076","LU1146622755.USD","BK0065","600522","SGXZ49509284.SGD","603877","BK0012","BK0167","01919","BK0148","601058","BK0264","BK0010","BK0125","BK0270","LU1820825898.SGD","BK0061"],"gpt_icon":0},{"id":"2483391322","title":"通化东宝:11月13日高管王君业增持股份合计5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483391322","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483391322?lang=zh_cn&edition=full","pubTime":"2024-11-15 20:01","pubTimestamp":1731672099,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月15日市场公开信息、上市公司公告及交易所披露数据整理,通化东宝最新董监高及相关人员股份变动情况:2024年11月13日公司董事王君业共增持公司股份5.0万股,占公司总股本为0.0025%。变动期间公司股价下跌0.45%,11月13日当日收盘报8.93元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500038428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","BK0188","600867"],"gpt_icon":0},{"id":"2483532167","title":"通化东宝控股股东权益变动达1% 增持股份超205万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483532167","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483532167?lang=zh_cn&edition=full","pubTime":"2024-11-15 19:05","pubTimestamp":1731668700,"startTime":"0","endTime":"0","summary":"财中社11月15日电通化东宝 发布关于控股股东及其一致行动人权益变动达到1%的提示性公告。此次权益变动是由于控股股东东宝集团及其一致行动人通过集中竞价方式增持公司股份,以及公司股份回购注销引起的持股比例被动增加,合计导致权益变动达到了1%。具体来看,东宝集团在2024年10月31日至2024年11月15日期间增持股份205万股,占公司总股本的0.1034%。此次增持计划不触及要约收购,且不会导致公司控股股东及实际控制人发生变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115190910abc473f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115190910abc473f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600867","BK0196","BK0239"],"gpt_icon":0},{"id":"2483268313","title":"通化东宝:公司胰岛素新的中标价格从各地执行时间要求时间点开始执行","url":"https://stock-news.laohu8.com/highlight/detail?id=2483268313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483268313?lang=zh_cn&edition=full","pubTime":"2024-11-15 19:00","pubTimestamp":1731668440,"startTime":"0","endTime":"0","summary":"证券之星消息,通化东宝(600867)11月15日在投资者关系平台上答复投资者关心的问题。投资者:您好,有一个问题想咨询下公司。胰岛素集采续约目前已经完成,我想问一下,由于每个省市执行的时间不同,对于贵公司胰岛素调价是以当地执行时间要求时间点开始执行新的中标价格么?通化东宝董秘:感谢您对公司的关注。公司胰岛素新的中标价格从各地执行时间要求时间点开始执行。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500034930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600867","BK0239","BK0196"],"gpt_icon":0},{"id":"2483347729","title":"11月15日通化东宝发布公告,其股东增持205.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483347729","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483347729?lang=zh_cn&edition=full","pubTime":"2024-11-15 18:01","pubTimestamp":1731664860,"startTime":"0","endTime":"0","summary":"证券之星消息,11月15日通化东宝发布公告《通化东宝:通化东宝关于控股股东及其一致行动人权益变动达到1%的提示性公告》,其股东东宝实业集团股份有限公司于2024年10月31日至2024年11月15日间合计增持205.01万股,占公司目前总股本的0.1034%,变动期间该股股价上涨3.74%,截止11月15日收盘报8.6元。股东增减持详情见下表:根据通化东宝2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500031612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600867","BK0196","BK0239"],"gpt_icon":0},{"id":"2482200088","title":"通化东宝:11月8日高管王君业增持股份合计14.82万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482200088","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482200088?lang=zh_cn&edition=full","pubTime":"2024-11-11 20:01","pubTimestamp":1731326478,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月11日市场公开信息、上市公司公告及交易所披露数据整理,通化东宝最新董监高及相关人员股份变动情况:2024年11月8日公司董事王君业共增持公司股份14.82万股,占公司总股本为0.0075%。变动期间公司股价下跌1.02%,11月8日当日收盘报8.73元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100026419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600867","BK0239","BK0196"],"gpt_icon":0},{"id":"2482276891","title":"通化东宝11月11日遭主力抛售2712万元 环比增加102.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482276891","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482276891?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:22","pubTimestamp":1731309736,"startTime":"0","endTime":"0","summary":"11月11日, 通化东宝股价涨0.46%,报收8.77元,成交金额2.27亿元,换手率1.31%,振幅1.95%,量比0.81。通化东宝今日主力资金净流出2712万元,连续4日净流出,上一交易日主力净流出1337万元,今日环比增加102.84%。近一年数据显示,该股主力连续4日净流出后,次日下跌概率为50.00%,平均跌幅为1.68%。该股近5个交易日上涨2.21%,主力资金累计净流出7942万元;近20日主力资金累计净流出1.72亿元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111154428a22bc351&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111154428a22bc351&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0188","BK0239","600867"],"gpt_icon":0},{"id":"2481769681","title":"通化东宝:11月7日高管王君业增持股份合计5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481769681","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481769681?lang=zh_cn&edition=full","pubTime":"2024-11-08 20:01","pubTimestamp":1731067283,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月8日市场公开信息、上市公司公告及交易所披露数据整理,通化东宝最新董监高及相关人员股份变动情况:2024年11月7日公司董事王君业共增持公司股份5.0万股,占公司总股本为0.0025%。变动期间公司股价上涨1.26%,11月7日当日收盘报8.82元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800038082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0239","600867"],"gpt_icon":0},{"id":"2481617988","title":"回购增持再贷款持续发力,超200亿元额度已“花落”74家上市公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2481617988","media":"银柿财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481617988?lang=zh_cn&edition=full","pubTime":"2024-11-08 19:50","pubTimestamp":1731066601,"startTime":"0","endTime":"0","summary":"自10月18日股票回购增持再贷款细则落地以来,运用这一工具的上市公司在持续增多。据银柿财经不完全统计,截至11月8日12时,至少已有74家上市公司发布有关股票回购增持再贷款的相关公告,总额超过200亿元,回购方面,53家上市公司共申请到136.19亿元的贷款额度;增持方面,22家上市公司申请到70.91亿元的贷款额度。目前,中国石化也是唯一一家两项贷款均参与的上市公司。上述12个行业,合计“贡献”了62家上市公司,占比高达84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108195036a2245d74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108195036a2245d74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","BK0155","600028","LU1979443071.USD","LU0823413660.USD","BK0201","BK0025","LU1934453819.USD","LU0231483743.USD","BK0187","LU2097828474.EUR","BK0028","601998","LU0516423091.SGD","BK0010","LU0823397103.USD","LU1146622755.USD","300498","LU2289578879.USD","600026","LU0821914370.USD","BK0015","601988","BK0077","LU1781817850.SGD","LU1023057109.AUD","BK0012","601939","600867","600036","LU2097828714.EUR","LU0651946864.USD","LU1820825898.SGD","SGXZ81163826.USD","BK0278","BK0006","LU0405327494.USD","LU1515016050.SGD","601168","BK0056","BK0188","002714","BK0175","BK0194","LU2580892862.HKD","LU0359201612.USD","LU0320764243.SGD","601398","LU1997245094.SGD","LU0823397285.USD"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1994-08-24","address":"吉林省通化市通化县东宝新村","stockEarnings":[{"period":"1week","weight":-0.0395},{"period":"1month","weight":-0.0339},{"period":"3month","weight":0.1683},{"period":"6month","weight":-0.0667},{"period":"1year","weight":-0.1985},{"period":"ytd","weight":-0.2178}],"companyName":"通化东宝药业股份有限公司","boardCode":"AI0027","perCapita":"20860股","boardName":"医药制造业","registeredCapital":"198173万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 通化东宝药业股份有限公司主要从事糖尿病及内分泌治疗领域生物制品、中成药、化学药等药品的研发、生产和销售。主要产品包括精蛋白人胰岛素混合注射液(30R)、精蛋白重组人胰岛素混合注射液(40/60)、精蛋白人胰岛素混合注射液(50R)、人胰岛素注射液、精蛋白人胰岛素注射液、甘精胰岛素注射液、门冬胰岛素注射液、门冬胰岛素30注射液、门冬胰岛素50注射液、利拉鲁肽注射液、瑞格列奈片、恩格列净片、镇脑宁胶囊。公司拥有国家级企业技术中心、国家GMP和欧盟GMP认证的生产车间。被国家认定为高新技术企业、国家技术创新示范企业、ISO14001环境体系认证企业。","serverTime":1734633952563,"listedPrice":6.5,"stockholders":"95000人(较上一季度减少1.59%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通化东宝(600867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通化东宝(600867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通化东宝,600867,通化东宝股票,通化东宝股票老虎,通化东宝股票老虎国际,通化东宝行情,通化东宝股票行情,通化东宝股价,通化东宝股市,通化东宝股票价格,通化东宝股票交易,通化东宝股票购买,通化东宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通化东宝(600867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通化东宝(600867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}